131 related articles for article (PubMed ID: 9641495)
41. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
42. Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction.
Chervoneva I; Hyslop T; Iglewicz B; Johns L; Wolfe HR; Schulz S; Leong E; Waldman S
Anal Biochem; 2006 Jan; 348(2):198-208. PubMed ID: 16336939
[TBL] [Abstract][Full Text] [Related]
43. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
44. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
[TBL] [Abstract][Full Text] [Related]
45. [The expression and clinical significance of keratin 19, 20 mRNA in different tumor cell lines and tumor tissues].
Qhiu L; Cong X; Ja L
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):32-5. PubMed ID: 11776592
[TBL] [Abstract][Full Text] [Related]
46. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.
Gessi S; Cattabriga E; Avitabile A; Gafa' R; Lanza G; Cavazzini L; Bianchi N; Gambari R; Feo C; Liboni A; Gullini S; Leung E; Mac-Lennan S; Borea PA
Clin Cancer Res; 2004 Sep; 10(17):5895-901. PubMed ID: 15355922
[TBL] [Abstract][Full Text] [Related]
47. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Witek ME; Nielsen K; Walters R; Hyslop T; Palazzo J; Schulz S; Waldman SA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8549-56. PubMed ID: 16361536
[TBL] [Abstract][Full Text] [Related]
48. Previstage GCC test for staging patients with colorectal cancer.
Mejia A; Waldmana SA
Expert Rev Mol Diagn; 2008 Sep; 8(5):571-8. PubMed ID: 18785805
[TBL] [Abstract][Full Text] [Related]
49. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
[TBL] [Abstract][Full Text] [Related]
50. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
51. Identification of a novel gene marker specific for epithelial cells by utilizing a 3'-directed cDNA library.
Ohnishi T; Tomita N; Miyoshi Y; Shinoki N; Tanaka T; Kawabata Y; Sekimoto M; Monden T; Okubo K; Matsubara K; Monden M
Cancer Res; 1998 Jun; 58(11):2440-4. PubMed ID: 9622086
[TBL] [Abstract][Full Text] [Related]
52. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Lubbe WJ; Zuzga DS; Zhou Z; Fu W; Pelta-Heller J; Muschel RJ; Waldman SA; Pitari GM
Cancer Res; 2009 Apr; 69(8):3529-36. PubMed ID: 19336567
[TBL] [Abstract][Full Text] [Related]
53. Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.
Camci C; Sahin A; Sevinc A; Kalender ME; Oztuzcu S; Sever ON; Ozkara E; Demiryürek AT
Tumour Biol; 2011 Dec; 32(6):1265-70. PubMed ID: 21901559
[TBL] [Abstract][Full Text] [Related]
54. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
Li P; Waldman SA
Cancer Biol Ther; 2010 Aug; 10(3):211-8. PubMed ID: 20592492
[TBL] [Abstract][Full Text] [Related]
55. Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.
Ciocca V; Bombonati A; Palazzo JP; Schulz S; Waldman SA
Histopathology; 2009 Aug; 55(2):182-8. PubMed ID: 19694825
[TBL] [Abstract][Full Text] [Related]
56. Sex modulates intestinal transformation by the tumor-suppressor GCC.
Li P; Schulz S; Pitari GM; Waldman SA
Clin Transl Sci; 2008 Sep; 1(2):146-50. PubMed ID: 20443837
[TBL] [Abstract][Full Text] [Related]
57. Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment.
Tórtola S; Capellà G; Marcuello E; Günther K; Aiza G; Masramon L; Reymond MA; Peinado MA
Lab Invest; 1998 Mar; 78(3):309-17. PubMed ID: 9520944
[TBL] [Abstract][Full Text] [Related]
58. GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?
Li P; Lin JE; Marszlowicz GP; Valentino MA; Chang C; Schulz S; Pitari GM; Waldman SA
Drug News Perspect; 2009; 22(6):313-8. PubMed ID: 19771320
[TBL] [Abstract][Full Text] [Related]
59. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.
Carrithers SL; Parkinson SJ; Goldstein SD; Park PK; Urbanski RW; Waldman SA
Dis Colon Rectum; 1996 Feb; 39(2):171-81. PubMed ID: 8620784
[TBL] [Abstract][Full Text] [Related]
60. Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.
Winn B; Tavares R; Matoso A; Noble L; Fanion J; Waldman SA; Resnick MB
Hum Pathol; 2010 Jan; 41(1):123-8. PubMed ID: 19800103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
